Quick Answer
ZEVRA THERAPEUTICS, INC. reported Long Term Debt of $61.93 million for the year ending 2025.
- ZEVRA THERAPEUTICS, INC. showed an increase of +4.1% in Long Term Debt from 2024 to 2025.
- This data is from ZEVRA THERAPEUTICS, INC.'s annual report (Form 10-K), filed with the SEC on March 9, 2026.
- XBRL data for this metric is available from 2023 to 2025 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2020: $781.0 thousand | Q3 2020: $781.0 thousand | Q2 2024: $58.33 million | Q3 2024: $58.90 million | Q1 2025: $60.09 million | Q2 2025: $60.69 million | Q3 2025: $61.31 million.
- Over the full 3 years of available data (2023 to 2025), ZEVRA THERAPEUTICS, INC.'s Long Term Debt has grown by 1,122.4%.
- Historical annual values: Fiscal year 2025: $61.93 million | Fiscal year 2024: $59.50 million | Fiscal year 2023: $5.07 million.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: